Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices
- 30 December 2002
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 58 (1) , 1-5
- https://doi.org/10.1002/ccd.10384
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockadeThe American Journal of Cardiology, 2000
- Immediate Post PTCA Percutaneous Suture of Femoral Arteries With the Perclose Device: Results of High Volume UsersJournal of the American College of Cardiology, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)Journal of the American College of Cardiology, 1995
- Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary InterventionCirculation, 1995
- Predictors of groin complications after balloon and new-device coronary interventionThe American Journal of Cardiology, 1995
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994
- Vascular complications after balloon and new device angioplasty.Circulation, 1993
- Peripheral vascular complications after conventional and complex percutaneous coronary interventional proceduresThe American Journal of Cardiology, 1992